Old Web
English
Sign In
Acemap
>
Paper
>
Current IST-free/relapse-free survival as a new endpoint after allogeneic hematopoietic stem cell transplantation.
Current IST-free/relapse-free survival as a new endpoint after allogeneic hematopoietic stem cell transplantation.
2020
Roberto Crocchiolo
Alessio Signori
Mohamad Sobh
Hélène Labussière
Myriam Renault
Fiorenza Barraco
Franck E. Nicolini
Mauricette Michallet
Keywords:
Diabetes mellitus
Hematology
Immunology
Medicine
Oncology
Hematopoietic stem cell transplantation
Internal medicine
relapse free survival
Correction
Source
Cite
Save
Machine Reading By IdeaReader
7
References
0
Citations
NaN
KQI
[]